Tufts: Growth in Rare Disease R&D Challenging Development Strategy and Execution


Applied Clinical Trials

According to a recently completed analysis from the Tufts Center for the Study of Drug Development, drug development for rare diseases presents scientific and operational challenges that will accelerate the adoption of new development strategies and operating models.

For more on their findings, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.